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Osteosarcoma is a metastatic primary malignancy of
bone arising from the mesenchyme. It has few known
genetic or environmental influences. It occurs most
frequently around the knee between the ages of 10
and 20 and over 50. Current treatment involves
chemotherapy and surgical removal, but 30%-40% of
the patients respond poorly (1). With the majority of
patients being young, and with the amount that
respond poorly to conventional treatment, there is
room for the introduction of new techniques in the
treatment. One such potentially new technique is
photodynamic therapy.
Photodynamic therapy (PDT) is a treatment for 
cancer which utilizes a photosensitizer and a specific 
wave length of light to produce reactive oxygen 
species (ROS) resulting in cell damage and death (2). 
5-aminolevulinic acid (ALA) is a prodrug favored for 
its lack of side effects (4). When treated with ALA, 
neoplastic cells accumulate the photosensitizer
protoporphyrin IX (PpIX) in the mitochondria. PpIX
is an intermediate in heme production in the cells, 
and when exposed to red light (635 nm), it results in 
ROS production (3). Singlet oxygen 
is believed to be the main cause of 
cell death, but due to its short life 
span within the cell (10-40 ns), it 
only damages the structures 
nearest to it, the mitochondria (2).
Therefore, we hypothesize that
ALA-mediated photodynamic
therapy will induce cell death via
mitochondrial mechanisms.
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Photodynamic therapy (PDT) is a novel approach
to cancer treatment that applies light and molecular
oxygen in combination with a photosensitizing
agent to selectively damage tumor tissue. The
present study evaluated the effectiveness of 5-
aminolevulinic acid (ALA) mediated PDT for
inducing in vitro death in MG-63 osteosarcoma
cells. To determine the accumulation of the
photosensitizer (protoporphyrin IX, PpIX) in
response to increasing ALA concentrations in the
osteosarcoma cells, cells were treated with varying
concentrations of ALA (0, 0.1, 0.25, 0.5, 1, 2, 5, 10
mM) for 4 and 24 h and the intracellular
conversion of ALA to PpIX was measured using
spectrofluorometry. To identify the optimal ALA
concentration and light exposure to induce
maximum cell death, cells were treated with
varying concentrations of ALA for 4 and 24 h and
then exposed to different light dosages (0, 0.5, 1, 5,
10 J/cm2) using an LED array (λ= 636 nm). Cell
viability was assessed using an MTT assay. It was
found that the highest PpIX accumulation occurred
in MG-63 cells treated with 0.5 mM and 1 mM
ALA for 24 h. Consistent with these results, the
greatest cell death was seen in cells treated with 0.5
mM and 1 mM ALA—there were more PpIX
within those cells to generate a greater number of
reactive oxygen species (ROS), the toxic element
in the PDT mechanism. Overall, these findings
suggest that ALA-mediated PDT significantly
induces MG-63 cell death, supporting its potential
use as a minimally invasive, alternative treatment
of human osteosarcoma.
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Figure 1. The LED array 
used for PDT.
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Results and Conclusion
PDT appears to be effective in killing MG-63 osteosarcoma cells.
While PDT results were inconsistent with only 4 hours of ALA
incubation; following 24 hour of ALA incubation significant cell
death was observed. Cell death increased with increasing light
exposure up to 10 j/cm2, the maximum tested. The same trend does
not appear to hold true for ALA concentrations. Cell death peaked
when cells were treated with 0.5 mM ALA and were exposed to 10
J/cm2 of light resulting in approximately 70% cell death. ALA
concentrations higher than 0.5 mM produced less death, and this
result is consistent with PpIX accumulation data.
Cells accumulated the most PpIX when treated with 0.5 mM or 1
mM ALA for both the 4 and 24 hr incubation periods and PpIX
accumulation decreased with ALA concentrations higher than 1
mM (figure 3). Less PpIX present in the cell would result in less
ROS production and less cell damage and death, as observed in the
PDT data.
The decreased accumulation of PpIX may be due to cytotoxic
effects of ALA. If ALA itself is killing cells then they would not be
expected to accumulate PpIX. While our own cytotoxicity assays
were inconclusive (data not shown), other studies have shown ALA
to be cytotoxic at concentrations above 3
mM (5). The cytotoxicity of ALA may
explain the results of PDT at the 5 and 10
mM ALA concentrations. At 5 and 10 mM
ALA concentrations, cell death remained
high relative to the decreased amount of
PpIX accumulation, and this may be due to
the combined effect of PDT and
cytotoxicity. Therefore, the maximum
effective dose of ALA for inducing cell
death via PDT is in the range of 0.5 to 1
mM for at least 24 hours.
